US EditionHHS chief RFK Jr. says he’s ordered a ‘complete review’ of chemical abortion pill
- On May 15, 2025, U.S. Health Secretary Robert F. Kennedy Jr. ordered the FDA to conduct a complete review of the abortion pill mifepristone amid new safety concerns.
- The review was initiated following a contentious analysis by a conservative think tank that reported serious adverse events in approximately 10.93% of users, a figure substantially higher than the rates reported in FDA clinical trials.
- Mifepristone, approved in 2000, is the first step in a medical abortion used in nearly two-thirds of U.S. abortions in 2023; the study's methodology and conclusions have drawn broad criticism from reproductive health experts.
- Kennedy stated that, minimally, changes need to be made to the medication’s labeling and assigned FDA director Marty Makary to thoroughly examine the data and provide recommendations on whether previously removed safety measures ought to be reinstated.
- The review may lead to FDA policy changes affecting access to the pill amid ongoing legal challenges and political efforts, signaling a shift in federal reproductive health regulation under Kennedy's leadership.
63 Articles
63 Articles
FDA Chief Commits To Full Review Of Abortion Pill
FDA Commissioner Marty Makary has committed to reviewing the abortion pill’s safety, according to Sen. Josh Hawley (R-MO).Hawley posted a letter he received from Makary on social media, noting the FDA head promised to review the safety of mifepristone, the popular abortion drug.“As the Commissioner of Food and Drugs, I am committed to conducting a review of mifepristone and working with the professional career scientists at the Agency who review…
A Texas bill to block abortion pills has died for now
A major Texas bill that was poised to offer a blueprint for abortion restrictions has likely died in the state legislature. Senate Bill 2880, a top priority for the state’s abortion opponents, would have targeted people who manufacture, distribute, mail or otherwise provide abortion medication in Texas. It would have enabled private citizens to sue people who distributed or provided abortion pills in Texas for a minimum of $100,000. Backers sai…
The Independent
The Independent (US)How ‘bogus’ science is pushing Trump officials to go after abortion drugs
Analysis: Health officials are reviewing a dubious report that claims dangerous complications from mifepristone. Public health researchers and scientists tell Julia Musto and Alex Woodward they’re extremely skeptical
MedPage Today
Anti-Aging, Acupuncture and Health NewsWaiting Period Extends Abortion Wait Beyond Mandatory 24 Hours
(MedPage Today) -- MINNEAPOLIS -- Mandatory 24-hour waiting periods between consent and abortion visits often resulted in much longer waits than required, a prospective survey study found. The median interval between the two visits was 3 days...
Coverage Details
Bias Distribution
- 66% of the sources lean Left
To view factuality data please Upgrade to Premium
